In reply: We thank Fourlanos and colleagues for their comments regarding our cluster randomised trial,1 which demonstrated that emergency department screening for diabetes and hyperglycaemia alone did not improve identification of diabetes, documentation of follow‐up plans, or hospital outcomes. The RAPIDS trial has shown that after identification through screening, intervention by a specialised inpatient diabetes team (IDT) is required to achieve improved outcomes.2 But this IDT comes with additional cost, which is a major barrier to the implementation of such teams around Australia.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
No relevant disclosures.